rice

Rep. Kathleen Rice, D-N.Y., speaks during the Bipartisan Heroin Task Force news conference on the release of the 2018 legislative agenda for the 115th Congress on Wednesday, Jan. 10, 2018. (Photo: Bill Clark/CQ Roll Call)

We're Going to Take on Big Pharma and Win the Fight to Lower Drug Prices

Any politician who puts Pharma profits before the needs of their constituents will lose their jobs. And they will deserve it.

On Wednesday, Rep. Kathleen Rice (D-NY) was one of three Democrats who cast a pivotal no vote in the House Energy and Commerce Committee. Rice shamefully voted against giving Medicare the power to negotiate lower drug prices as part of the $3.5 trillion Build Back Better package.

Despite the setback, we're going to win. We're going to give Medicare negotiating power to lower drug prices for everyone. And Pharma is scared.

It's hard to find a policy more popular with voters across the spectrum than taking on Pharma greed and lowering drug prices.

Pharma is so scared that they've launched a massive campaign against giving Medicare negotiating power. Pharma's lobbying frenzy includes multi-million dollar TV ad buys and spending over $6 million from April to June of this year on lobbying (a 19% increase during the same time last year).

Any politician who listens to Pharma and puts profits over people's lives deserves to wear that shame forever. That's why we have a mobile billboard in Rice's Long Island district to let her constituents know she betrayed them. Clearly, Rice needs a reminder that she works for the people of New York's fourth Congressional district, not Pharma.

It will come as no surprise that Rice (along with the other no voters Rep. Scott Peters (D-CA) and Rep. Kurt Schrader (D-OR)) is in the pockets of Pharma. Rice has received $84,259 from campaign contributions from pharmaceutical and health corporations during her congressional career. And Peters and Schrader have collectively taken an appalling $1.7 million from Pharma during their time in Congress.

Congresswoman Rice on drug prices

Rice's betrayal may come as a surprise to her constituents because Rice campaigned for years on taking on Pharma's greed. And that's why Rice is the perfect example of everything wrong with status quo corporate politicians.

Rice claimed to support the lowering of prescription drugs. In an October 2020 campaign ad, Rice promised to "always put the health and safety of Long Island first."

Not to mention, an overwhelming 90 percent of Rice's constituents support giving Medicare the power to negotiate lower drug prices. It's hard to find a policy more popular with voters across the spectrum than taking on Pharma greed and lowering drug prices.

But when given the chance to make good on that promise, and represent the interests of 90% of her constituents, Rice still sided with Pharma and betrayed the people she works for.

But that's exactly why we're going to continue to fight for--and win--lower drug prices. We're going to win because the American people--and the vast majority of the Democratic caucus and President Biden--are on our side. We have the people, and we also have some big guns on our side spending money, AARP just dropped $4 million on an ad buy pushing for Medicare negotiation.

That is why carrying water for Pharma is not only a moral failure, it is also a political failure. Any politician who puts Pharma profits before the needs of their constituents will lose their jobs. And they will deserve it.

Pharma shills simply aren't fit to represent the people of their districts.

Join Us: News for people demanding a better world


Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place.

We're hundreds of thousands strong, but every single supporter makes the difference.

Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. Join with us today!

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.